<DOC>
	<DOCNO>NCT00728897</DOCNO>
	<brief_summary>Study compare PK new 100mg capsule four 25mg capsule . This required plan single capsule administer later phase clinical trial 100mg strength . As new previously untested strength need ensure PK similar achieve use 4 x 25mg . The study also assess effect high fat food PK 100mg capsule . The study plan consist single part , three dose period , period 1-3 consist 16 subject . There week wash dose . In three dose period subject either receive 4x25 mg GSK598809 capsule fast state , 100mg capsule fast state 100mg GSK598809 capsule feed state . Subjects return centre follow-up 7-14 day final dose . It expect total duration study approximately eight week .</brief_summary>
	<brief_title>A Healthy Volunteer Study Investigate Relative Bioavailability Two Forms GSK598809 Capsules .</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Inclusion : Healthy determine responsible physician . Male female 18 65 year old . Females nonchild bear potential female childbearing potential agree use appropriate method contraception appropriate amount time . Males agree use appropriate method contraception appropriate amount time . Neither fat thin . Capable give write informed consent compliant requirement within informed consent . Exclusion : Any current medical psychiatric illness . Any history chronic medical psychiatric illness . Previous current alcohol drug abuse/dependence include nicotine . Female subject must breastfeed breastfeed month . Serum prolactin exceed normal range . Personal family history prolong QTc syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>relative bioavailability .</keyword>
</DOC>